MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss from
continuing operations...
-$1,153,933
Net income (loss)
-$922,723
(58.45%↑ Y/Y)
Preferred stock dividend
and cash premiums
$231,210
(-78.02%↓ Y/Y)
Loss from continuing
operations, net of tax
-$922,723
Interest income
$67,014
(-11.61%↓ Y/Y)
Change in fair value of
warrant liability
-$1,000
Loss before income
taxes
-$922,723
(58.45%↑ Y/Y)
Total other income,
net
$68,014
(-42.89%↓ Y/Y)
Loss from continuing
operations
-$990,737
(57.66%↑ Y/Y)
Total operating
expenses
$990,737
(-72.70%↓ Y/Y)
Selling, general and
administrative
$990,737
(-56.95%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Petros Pharmaceuticals, Inc. (PTPI)
Petros Pharmaceuticals, Inc. (PTPI)